Sort by
Keyphrases
Vagus Nerve Stimulation
100%
Therapeutic Approaches
100%
Chronic Heart Failure
100%
Left Ventricular Function
75%
Quality of Life
50%
Heart Failure Patients
50%
New York Heart Association Class
50%
Device-independent
50%
Stimulation Mechanism
25%
Left Ventricular Ejection Fraction
25%
Tolerability
25%
Two-staged
25%
Increased Mortality
25%
Patient Safety
25%
Controlled Experiment
25%
Stimulus Intensity
25%
6-minute Walk Test (6MWT)
25%
1-year Follow-up
25%
Surgical Revision
25%
Clinical Efficacy
25%
Serious Adverse Events
25%
Cough
25%
Nerve Stimulation
25%
Systolic Dysfunction
25%
Pulmonary Edema
25%
LV Ejection Fraction
25%
Vagal Activity
25%
Non-serious
25%
Intensity Adjustment
25%
Systolic Volume
25%
Drug-refractory Epilepsy
25%
Implantable Systems
25%
Acute Decompensation
25%
Dysphonia
25%
Biocontrol
25%
Postoperative Pulmonary
25%
Patient Tolerability
25%
Cervical Vagus Nerve Stimulation
25%
Class Quality
25%
INIS
nerves
100%
stimulation
100%
vagus
100%
heart failure
100%
patients
87%
devices
25%
safety
25%
quality of life
25%
new york
25%
data
12%
volume
12%
surgery
12%
drugs
12%
mortality
12%
epilepsy
12%
refractories
12%
implants
12%
clinical trials
12%
death
12%
edema
12%
adjustments
12%
pain
12%
Medicine and Dentistry
Vagus Nerve Stimulation
100%
Congestive Heart Failure
100%
Quality of Life
33%
Heart Left Ventricle Function
33%
New York Heart Association Class
33%
Coughing
16%
Systolic Dysfunction
16%
Adverse Event
16%
Heart Left Ventricle Ejection Fraction
16%
Six Minute Walk Test
16%
Ejection Fraction
16%
Neurostimulation
16%
Implant
16%
Controlled Clinical Trial
16%
Patient Safety
16%
Pulmonary Edema
16%
Drug Resistant Epilepsy
16%
Surgical Revision
16%
Dysphonia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Tolerability
50%
Coughing
25%
Systolic Dysfunction
25%
Adverse Event
25%
Implant
25%
Controlled Clinical Trial
25%
Dysphonia
25%
Drug Resistant Epilepsy
25%
Lung Edema
25%